This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Felix Schmidt: Innovator in Therapeutic Agents for Neurodegenerative Diseases
Introduction: Felix Schmidt, a distinguished inventor based in Munich, Germany, is recognized for his significant contributions to the field of therapeutic agents aimed at treating neurodegenerative diseases. With a keen focus on enhancing the solubility and bioavailability of medicinal compounds, his innovations hold promise for conditions such as Alzheimer's and Parkinson's diseases.
Latest Patents: Schmidt holds one patent titled "Water-soluble derivatives of 3,5-diphenyl-diazole compounds." This invention addresses the need for effective therapeutic agents that can inhibit protein aggregation in diseases related to neurodegeneration. The modified 3,5-diphenyl-diazole derivatives offer improved solubility in aqueous solutions, thus increasing their bioavailability and therapeutic potential against conditions like Alzheimer's disease, Parkinson's disease, and Creutzfeldt-Jakob disease.
Career Highlights: Felix Schmidt's career at the Max Planck Society for the Advancement of Science has been marked by groundbreaking research and innovation in medical chemistry. His dedication to improving therapeutic approaches has established him as a notable figure in the realm of drug development, particularly concerning neurodegenerative disorders.
Collaborations: Schmidt has collaborated with distinguished colleagues Armin Giese and Christian Griesinger, working together to further advancements in the pharmaceutical application of 3,5-diphenyl-diazole derivatives. Their combined efforts are pushing the boundaries of current treatment options for diseases plagued by protein aggregation.
Conclusion: With his invention of water-soluble derivatives of 3,5-diphenyl-diazole compounds, Felix Schmidt represents a crucial player in the ongoing fight against neurodegenerative diseases. His work not only enhances the availability of effective treatments but also exemplifies the importance of innovation in medical science, paving the way for future breakthroughs in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile